Subsidy of more than 180,000 euros for research into the quality of life of adults with NF1!
Sarah van Dijk, nurse specialist at Erasmus MC, has received a personal grant of more than 180,000 euros for her research into improving the quality of life of adults with neurofibromatosis type 1 (NF1), the DAISY study.
Continue ReadingNew guidelines published: 'management of tumors in NF1'
The new guideline for 'Policy for tumors in NF1' was recently published from ERN GENTURIS. The guideline group was chaired by ianne Oostenbrink, pediatrician at Erasmus MC, and coordinator of the EMC-NF1 expertise center. A number of colleagues from the EMC also contributed to the formation of the new guideline.
Continue ReadingENCORE's Angelman research presented at the ASA research conference!
Met een grote delegatie van meer dan 10 artsen en onderzoekers bezocht ENCORE het Angelman onderzoekscongres van de Angelman Syndrome Alliance
Continue ReadingA peek inside the Sophia Bus during Expedition NEXT!
On Friday May 6, we took our Sophia Bus to Expedition NEXT, the national science festival for children, organized by the National Science Day. Here children could take a peek into our Sophia Bus!
Continue ReadingAgain official recognition for all ENCORE Expertise centers
At the beginning of October, we as ENCORE Expertise Center received fantastic news! All our centers of expertise are recognized by the Dutch Federation of University Medical Centers (NFU) for a period of 5 years.
Continue ReadingProf.dr. Ype Elgersma tells in the Belgian newspaper about gene therapy for Angelman Syndrome
Prof.dr. Ype Elgersma, head of ENCORE research, was recently interviewed by the Belgian newspaper ‘De Standaard’ about the potential of new gene therapies as a treatment for congenital brain disorders.
Continue Reading